The Latest Breaking News from Steve Reitmeister

The Top 3 Growth Stocks to Add to Your Portfolio Today

In the current market backdrop, where the Federal Reserve is expected to continue raising interest rates, investing in growth stocks can help weather the storm. Fundamentally sound growth stocks such as Expedia Group (EXPE), Extreme Networks (EXTR), and FutureFuel Corp. (FF) could be wise additions to your portfolio. Read on….

StockNews.com · Jun 21, 2023

Salesforce (CRM): Should Investors Buy This Stock Now?

Software company Salesforce (CRM) is largely incorporating AI into its operations. Looking at AI’s potential after the launch of ChatGPT, should investors consider buying CRM now? Let’s look at its financial metrics to know more….

StockNews.com · Jun 21, 2023

3 Must Need Software Stocks to Buy

Rising investments in digital transformation and the adoption of emerging technologies are driving the demand for software solutions. Amid this backdrop, it could be wise to buy fundamentally strong software stocks Commvault Systems (CVLT), IBEX Limited (IBEX), and eGain Corporation (EGAN). Read more.

StockNews.com · Jun 21, 2023

1 Tech Stock to Buy, 2 Worth Watching

Amidst the rising digital transformation coupled with the growing tech inclination, the tech sector is poised for growth. Thus, Nomura Research Institute (NRILY) could be worth buying. However, I think its best to wait for a better entry point in Accenture plc (ACN) and Wipro (WIT). Read on.

StockNews.com · Jun 21, 2023

3 Bank Stocks to Keep Watching

Despite signs of improving sentiment around the U.S. banking system, investors and depositors remain concerned about its stability. Therefore, it could be wise to add fundamentally strong foreign banks KB Financial Group (KB), Banco Macro (BMA), and Banco BBVA Argentina (BBAR) to one’s watchlist. Keep reading….

StockNews.com · Jun 21, 2023

Moderna (MRNA) vs. BioNTech (BNTX): Which Biotech Stock Should You Be Investing In?

Amidst the biotech industry’s rapid growth and notable advancements, let’s analyze which of the two major players, Moderna (MRNA) and BioNTech (BNTX), is a more favorable investment choice in the current uncertain economic climate. Keep reading to find out.

StockNews.com · Jun 21, 2023

Should You Buy These 3 Asset Management Stocks?

The asset management sector is well-poised for robust growth this year and beyond, thanks to growing demand for optimal asset utilization, rising need for efficient tracking and management of assets, and adoption of digital technologies. So, let’s find out if you should invest in these asset management stocks Owl Rock…

StockNews.com · Jun 21, 2023

Investing with Occam’s Razor

Time to get philosophical about the outlook for the market with the help of Occam’s Razor. This tool tells us to assume that the simplest explanation is the most likely. Now lets apply that to recent Fed statements for what that tells us about the next move for the stock…

StockNews.com · Jun 20, 2023

Powell to Investors: Do You Feel Lucky Punk?

The “seeming” post Fed meeting rally for the S&P 500 is head scratcher for sure. That’s because as we dig below the surface, the overall market has not really rallied…just the usual suspects in the mega cap space. As you dissect the Fed statements there is a great divide in…

StockNews.com · Jun 16, 2023

Is Bionano Genomics (BNGO) a Buy or Sell this Week?

Genomic testing devices manufacturer Bionano Genomics (BNGO) is witnessing steady revenue growth. However, unfortunately, it did not translate into a bottom-line improvement. Moreover, as BNGO faces the possibility of delisting, is it worth buying now? Keep reading.

StockNews.com · Jun 16, 2023